OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Monash University

2 Projects | 2 Researchers | $1,116,321 Invested

2025

Monash University

Joanne Ryan, PhD

Leveraging a large scale randomized clinical trial to determine whether statins can prevent Alzheimer’s Disease neuropathology and dementia

  • Funding Amount: $424,461
  • Organization Type:
  • Program: Prevention
  • Target: Vascular
  • Status: Active

2021

Monash University

Matthew Pase, PhD

Plasma neuroinflammatory biomarkers for the diagnosis of dementia subtypes

  • Funding Amount: $691,860
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Neuroinflammation
  • Status: Active